Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1307)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
678
Price
$528.85
Total Value
$358.56K
Shares Held After
210
% of Holdings
76.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,066
Price
$527.95
Total Value
$562.80K
Shares Held After
888
% of Holdings
54.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$526.60
Total Value
$126.38K
Shares Held After
1,954
% of Holdings
10.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$524.85
Total Value
$62.98K
Shares Held After
2,194
% of Holdings
5.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
165
Price
$523.52
Total Value
$86.38K
Shares Held After
2,314
% of Holdings
6.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
335
Price
$522.02
Total Value
$174.88K
Shares Held After
2,479
% of Holdings
11.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
465
Price
$520.87
Total Value
$242.20K
Shares Held After
2,814
% of Holdings
14.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$519.99
Total Value
$270.40K
Shares Held After
3,279
% of Holdings
13.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
361
Price
$518.80
Total Value
$187.29K
Shares Held After
3,799
% of Holdings
8.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
319
Price
$517.83
Total Value
$165.19K
Shares Held After
4,160
% of Holdings
7.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
588
Price
$516.64
Total Value
$303.79K
Shares Held After
4,479
% of Holdings
11.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
678
Price
$515.81
Total Value
$349.72K
Shares Held After
5,067
% of Holdings
11.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
565
Price
$514.90
Total Value
$290.92K
Shares Held After
5,745
% of Holdings
9.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
676
Price
$513.65
Total Value
$347.23K
Shares Held After
6,310
% of Holdings
9.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
603
Price
$512.88
Total Value
$309.27K
Shares Held After
6,986
% of Holdings
7.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
896
Price
$511.73
Total Value
$458.51K
Shares Held After
7,589
% of Holdings
10.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
701
Price
$510.81
Total Value
$358.07K
Shares Held After
8,485
% of Holdings
7.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
244
Price
$509.49
Total Value
$124.32K
Shares Held After
9,186
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$500.05
Total Value
$100.01K
Shares Held After
9,430
% of Holdings
2.1%
ADMA BIOLOGICS, INC. (ADMA)
Kestenberg-Messina Kaitlin M. — COO and SVP, Compliance
Shares
10,096
Price
$15.63
Total Value
$157.80K
Shares Held After
466,600
% of Holdings
2.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
30,941
Price
$14.79
Total Value
$457.62K
Shares Held After
647,809
% of Holdings
4.6%
KalVista Pharmaceuticals, Inc. (KALV)
Palleiko Benjamin L — Director
Shares
6,693
Price
$16.08
Total Value
$107.63K
Shares Held After
451,815
% of Holdings
1.5%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
7,931
Price
$60.72
Total Value
$481.57K
Shares Held After
391,673
% of Holdings
2.0%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research & Development
Shares
2,907
Price
$60.72
Total Value
$176.51K
Shares Held After
138,629
% of Holdings
2.1%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
2,582
Price
$60.72
Total Value
$156.78K
Shares Held After
47,858
% of Holdings
5.1%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
50,000
Price
$19.03
Total Value
$951.47K
Shares Held After
964,161
% of Holdings
4.9%
Jazz Pharmaceuticals plc (JAZZ)
Carr Patricia — SVP, Chief Accounting Officer
Shares
1,287
Price
$182.94
Total Value
$235.44K
Shares Held After
6,512
% of Holdings
16.5%
NewAmsterdam Pharma Co N.V. (NAMS)
Kastelein Johannes Jacob Pieter — Director
Shares
101,409
Price
$30.29
Total Value
$3.07M
Shares Held After
69,302
% of Holdings
59.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$484.27
Total Value
$77.48K
Shares Held After
130
% of Holdings
55.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
450
Price
$483.69
Total Value
$217.66K
Shares Held After
290
% of Holdings
60.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$482.74
Total Value
$96.55K
Shares Held After
740
% of Holdings
21.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$481.59
Total Value
$115.58K
Shares Held After
940
% of Holdings
20.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
938
Price
$480.47
Total Value
$450.68K
Shares Held After
1,180
% of Holdings
44.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
582
Price
$479.63
Total Value
$279.14K
Shares Held After
2,118
% of Holdings
21.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,212
Price
$478.32
Total Value
$579.72K
Shares Held After
2,700
% of Holdings
31.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,194
Price
$477.53
Total Value
$1.05M
Shares Held After
3,912
% of Holdings
35.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
880
Price
$476.37
Total Value
$419.20K
Shares Held After
6,106
% of Holdings
12.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,118
Price
$475.36
Total Value
$531.45K
Shares Held After
6,986
% of Holdings
13.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,001
Price
$474.12
Total Value
$474.60K
Shares Held After
8,104
% of Holdings
11.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
241
Price
$473.23
Total Value
$114.05K
Shares Held After
9,105
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
284
Price
$471.96
Total Value
$134.04K
Shares Held After
9,346
% of Holdings
2.9%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
400
Price
$100.19
Total Value
$40.08K
Shares Held After
324,879
% of Holdings
0.1%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
16,015
Price
$99.29
Total Value
$1.59M
Shares Held After
325,279
% of Holdings
4.7%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
13,585
Price
$98.59
Total Value
$1.34M
Shares Held After
341,294
% of Holdings
3.8%
Acumen Pharmaceuticals, Inc. (ABOS)
Meisner Derek M — Chief Legal Officer & Corp Sec
Shares
2,090
Price
$3.26
Total Value
$6.81K
Shares Held After
173,999
% of Holdings
1.2%
NewAmsterdam Pharma Co N.V. (NAMS)
LANGE LOUIS G — Director
Shares
28,186
Price
$29.41
Total Value
$828.95K
Shares Held After
0
% of Holdings
100.0%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
30,941
Price
$15.14
Total Value
$468.45K
Shares Held After
652,147
% of Holdings
4.5%
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
10,000
Price
$29.58
Total Value
$295.84K
Shares Held After
51,000
% of Holdings
16.4%
Ultragenyx Pharmaceutical Inc. (RARE)
Parschauer Karah Herdman — EVP and Chief Legal Officer
Shares
6,018
Price
$21.40
Total Value
$128.79K
Shares Held After
70,328
% of Holdings
7.9%
Dyne Therapeutics, Inc. (DYN)
Posner Brian S — Director
Shares
3,000
Price
$15.06
Total Value
$45.18K
Shares Held After
11,500
% of Holdings
26.1%
Showing 451–500 of 1307 transactions (page 10 of 27)